Log in or Sign up for Free to view tailored content for your specialty!
Interstitial Lung Disease News
Progressive massive fibrosis continues to impact coal miners in 2023
Between 2017 and 2023, more than 1,000 cases of progressive massive fibrosis emerged in coal miners, according to a research letter published in JAMA.
Palliative telecare team improves quality of life in COPD, ILD
Receiving care from a palliative telecare team resulted in more improvements in quality of life than usual care among patients with COPD, interstitial lung disease or heart failure, according to study results published in JAMA.
Log in or Sign up for Free to view tailored content for your specialty!
Consuming omega-3 fatty acids may reduce pulmonary fibrosis progression
In patients with pulmonary fibrosis, consuming omega-3 fatty acids may improve diffusing capacity for carbon monoxide and lengthen survival, according to results published in CHEST.
Severe OSA linked to poorer lung function over time
Over time, adults with severe obstructive sleep apnea had more high attenuation areas on CT and lower lung function, which may signal early interstitial lung disease, according to data published in Annals of the American Thoracic Society.
Climate change poses ‘major threat’ to respiratory health
The historical climate events of the past summer may have been eye-opening for all, but the health of patients with respiratory diseases and conditions has been particularly threatened due to these exposures.
Hospitalization, mortality risks in RA-ILD similar for TNF inhibitors, non-TNF agents
SAN DIEGO — TNF inhibitors demonstrate comparable risks for hospitalization and death vs. non-TNF agents in patients with rheumatoid arthritis-associated interstitial lung disease, according to data presented at ACR Convergence 2023.
ILD treatment differs by sex, race across countries
The prevalence of patients with interstitial lung disease who receive treatment varied across countries, with some sex- and race-based differences, according to results published in CHEST.
Understanding risk factors, progression of interstitial lung abnormalities
Knowing that interstitial lung abnormalities heighten interstitial lung disease and all-cause mortality risk, it is important that pulmonologists know how to recognize and distinguish these abnormalities.
Interstitial lung disease can develop ‘in any stage’ of systemic sclerosis
SAN DIEGO — Shortness of breath, male sex, age and elevated inflammatory markers are all more predictive of new interstitial lung disease in systemic sclerosis than disease duration, according to data presented at ACR Convergence 2023.
Real-world monitoring of rheumatoid arthritis-associated ILD ‘suboptimal’
SAN DIEGO — Monitoring of rheumatoid arthritis-associated interstitial lung disease remains highly variable and “suboptimal” in the real world, according to a speaker at ACR Convergence 2023.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read